TSS
NERV icon

Two Sigma Securities’s Minerva Neurosciences NERV Stock Holding History

Two Sigma Securities’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,140
Closed -$14K – 2644
2022
Q1 		$14K Buy
+2,140
New +$13.1K ﹤0.01% 2021
2021
Q4 		– Sell
-2,099
Closed -$29K – 1882
2021
Q3 		$29K Buy
+2,099
New +$31.6K ﹤0.01% 1434
2020
Q3 		– Sell
-1,410
Closed -$41K – 1546
2020
Q2 		$41K Buy
+1,410
New +$82.7K ﹤0.01% 1261

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Securities's NERV Position: Q2 2022 in Review

Two Sigma Securities sold out of Minerva Neurosciences (NERV) in Q2 2022, closing a stake of 2,140 shares — an estimated $14K sold.

Two Sigma Securities first reported a position in NERV in Q2 2020 and held it in 3 quarters. The position peaked at $41K in Q2 2020. 23 funds tracked by Wall St. Rank hold NERV as of Q2 2022.

  • Two Sigma Securities reported no remaining Minerva Neurosciences position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,140 Minerva Neurosciences shares in Q2 2022, an estimated $14K.
  • Two Sigma Securities first reported a position in Minerva Neurosciences in Q2 2020 and held it in 3 quarters.
  • Two Sigma Securities's Minerva Neurosciences position peaked at $41K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2022.

Based on Two Sigma Securities's 13F filing for Q2 2022, filed 15 Aug 2022.